Upload
mdshakhaowat-hossain
View
218
Download
0
Embed Size (px)
Citation preview
8/8/2019 Protein Sources Final
1/34
Protein Sources
Choice of protein source:
A prerequisite to the isolation, characterization and/or utilization of any
protein is the identification of a suitable protein source.
In a few cases the desired protein may be unique to a specific species or be
produced by a very restricted member of species; e.g., the gonadotrophic
hormone pregnant mare serum gonadotrophin (PMSG) is found in only equids.
Under such circumstances, the choice of protein source is already made.
In most cases, however, the protein of interest will be produced by a range of
species, providing a choice of source. The purpose for which the protein is
required will also influence this choice.
If the protein is to be used for an applied industrial purpose, choice must be
made very carefully.
Recombinant versus non-recombinant production
Low natural expression levels has rendered difficult the isolation, study and
application of a range of proteins from native sources. Such difficulties have
been overcome with the advent of recombinant DNA technology. Now-a-
days, in principle, the gene or cDNA coding for any protein (of known or
unknown function) can be isolated and inserted into an appropriated
expression system; and a very large number of proteins are now produced by
recombinant means.
Start from here
Microorganisms as a source of proteins:
Many proteins of industrial interests are obtained from (non-recombinant) microbial
sources.
The majority are synthesized by a limited number of microorganisms which are
classified as a GRAS (Generally Recognized As Safe).
GRAS listed microbes are:
8/8/2019 Protein Sources Final
2/34
Non-toxic and
Generally should not produce antibiotics
GRAS microorganisms include bacteria such as
Bacillus subtilis
Bacillus amyloliquefaciens
Various other bacilli
Lactobacilli and
Streptomyces spp.
GRAS listed fungi include members of
Aspergillus
Penicillium
Mucorand
Rhizopus
Yeast such as Saccharomyces
cerevisiae are also recognized as safe.
8/8/2019 Protein Sources Final
3/34
..
Microorganisms represent an attractive source of protein as
a)They can be cultured in large quantities over a relatively short time period by
established method of fermentation.
b)They can produce an abundant regular supply of desired protein product
c) Microbial proteins are often more stable than analogous proteins obtained
from plant or animal sources.
d) Microbes can be subjected to genetic manipulation more readily than animals
or plants.
Types of proteins:
Extracellular
Intracellular
Extracellular protein products:
Many industrially significant proteins obtained by methods of fermentation are
secreted by the producing microorganism directly into the culture medium.
Advantages:
Such extracellular protein production greatly simplifies subsequent downstream
processing as there is no requirement to disrupt the microbial cells in order to
release desired proteins.
There are fewer extracellular proteins from which it is easy to separate product
of interest.
Whole cells may be removed from protein containing extracellular media by
methods such as centrifugation or filtration.
Few subsequent purification steps are required for final product of recovery.
Specific examples of industrially important protein secreted into the extracellular
medium during fermentation include-
Various amylolytic and proteolytic enzymes produced by bacilli
Cellulases and other activities produced by fungi such as Trichoderma viridiae
Intracellular protein products:
8/8/2019 Protein Sources Final
4/34
In some instances the protein of interest many be intracellular. In such cases it
becomes necessary to disrupt the cells upon completion of fermentation and
cell harvesting.
Such approach releases not only the protein of interest but also the enteric
intracellular content of the cell. This, in turn, renders more complicated the
subsequent purification procedures required to obtain the final product.
Specific examples of intracellular proteins of industrial significance include
Asperaginase
Penicillin acylase and
Glucose isomerase
General steps for obtaining a protein of interest: (traditional methods)
1. Traditionally identification of the most suitable microbial protein source
involved screening a wide range of candidate microorganisms.
2. The existence of simple, rapid and sensitive assay to identify the protein of
interest greatly facilitates such screening activities.
3. Initial screens serve to identify microbial species expressing the protein of
interest.
4. Further screens pinpoint microbial species producing the largest quantities of
the protein.
5. Frequently, organisms found to produce elevated levels of protein of interest
are subjected to mutational studies using chemical mutagens or UV-light, in
an effort to isolate overproducing strains.
Advantageous mutations can result in product enhancement in two ways:
1. A mutation in the regulation sequence of the gene encoding the desired
protein can result in increased levels of expression of the gene product.
2. A mutational event occurring in the gene itself(direct) can result in
an altered amino acid sequence which may render the protein more
functionally efficient or
Enhance its stability.
Example:
1. Soil bacteria are amongst the most common group of organisms subjected to
routine screening. Soil bacilli (apart from B. cereus group) are suitable
d th ll f t GRAS i t
8/8/2019 Protein Sources Final
5/34
They are also easily cultured in simple media and produce variety of
industrially important enzymes extracellularly.
2. Hundreds of different species of fungi also inhabit the soil, especially near the
soil surface where aerobic conditions prevail. Such fungi are active in
degrading a wide variety of biological materials present in the soil.
They thrive on such material largely by secreting extracellular enzymes
(cellulases, pectinase) capable of degrading large polymeric plant molecules
such as cellulose, hemicelluloses and pectin with subsequent assimilation of
the liberated nutrients.
Protein production in genetically engineered microorganism:
Genetic manipulation by mutation and selection has played a central role in
increasing expression levels of a myriad of microbial proteins. This approach,
however, could be at best described as haphazard, because, researchers have
little control over the genetic alterations achieved, and thus goal (expected
improvement in protein productivity) can be achieved only by chance.
On the other hand, recombinant DNA technology can be utilized in a highly
directed manner to achieve specific genetic alterations and rational
improvements in source productivity.
Strain improvements by trial and error mutational methods will continue to
play a role, as large numbers of such experiments can be carried out
conveniently and relatively inexpensively if suitable screening procedures are in
place to detect the desired product,
Recombinant DNA technology can be used to increase the levels of production of an
endogenous microbial protein by a number of methods. These include:
a) Introduction of additional copies of the relevant gene into the microorganism
b) Introduction of a copy or copies of the relevant gene into the organism where
control of expression has been placed under a more powerful promoter.
Such strategies can result in a several-fold increase in production of the protein of
interest.
We can use genetically engineered microorganism to produce the desired gene
because:
1. They are less expensive
8/8/2019 Protein Sources Final
6/34
2. The technique is simple
3. Production is easily controllable
4. Heterologous proteins can be produced
5. Production rate is high.
Heterologous protein expression systems
Heterologous protein production in E. coli:
The expression of recombinant proteins in cells in which they do not naturally occur
is termed heterologous protein production. Bacterial expression systems are
commonly used for production of heterologous gene products of both eukaryotic
and prokaryotic origin. The expression of heterologous proteins in E.coli, which is
the bacterial system, is most widely and routinely used. A number of
therapeutically important proteins are now produced as heterologous in E.coli. The
first heterologous protein to be empolyed clinically was human insulin produced in
E.coli first approved 1982, UK, West Germany, Netherland, USA.
General considerations of selecting E.coli as heterogeneous protein
expression host
E.coli is widely used as the host for heterogeneous protein expression for the
following advantages:
1. Ease of growth and manipulation using simple laboratory equipments.
2. Availability of dozens of vectors and host strains that have been developed
for maximizing expression.
3. A wealth of knowledge about the genetics and physiology ofE.coli
4. Expression can often be achieved quite rapidly beginning with a eukaryotic
cDNA clone, express the protein in E.coli and purify in miligram quantities in
less than 2 weeks.
5. Suitable fermentation technology well established.
6. Can generate potentially unlimited supplies of recombinant protein.
7. Economically attractive.
Limitations using E coli as heterogeneous protein expression host
8/8/2019 Protein Sources Final
7/34
1. Inability ofE. coli as a prokaryotic to carry out post translational modification
which is typical for Eukaryotic. (glycosydation, phosphorylation, acetylation).
2. Limited ability to carryout extensive disulfide bond formation . (assembly of
heterologous proteins are less formed, thus active proteins are not formed).
3. Some proteins are made in insoluble form, a consequence of protein
misfolding, aggregation and intracellular accumulation as inclusion bodies.
(when expression level is high-chance of IB is large, also depends on the
nature of the proteins; thus form inactive form).
4. Some times sufficient expression may not be observed due to protein
degradation or insufficient translation (mRNA may remain in secondary
structure and translation hampered)
5. Codon sequence for a specific amino acid in Eukaryotic is different from
Prokaryotic as E.coli. This phenomenon is known as codon bias which
vastly hampers protein synthesis and gene expression in E.coli.
Most common problem:
Inadequate expression levels
Poor product solubility
These limitations of gene expression in E.coli can be over come by two major ways:
a. Improving the level of expression
b. Improving the solubility of the protein
Improving the level of expression
The level of expression is sometimes inadequate to meet all the need, even when
expression systems are used that employ strong transcriptional and translational
signals; level of expression can be improved by:
a) Induction condition
b) Coding sequence of the heterologous gene
c) Use of protease deficient host strains
a) Induction condition:
Induction conditions depend on the protein expression system (vector, operon, host
media etc) Varying the time and/or temperature of induction of expression of
8/8/2019 Protein Sources Final
8/34
heterologous protein is to find out the optical conditions of product accumulation.
Induction can be done with
chemical e.g., IPTG for lac operon; or
physical-Pll system allows induction by temperature.
Changing the composition of the growth media can also
improve expression in some cases.
Some proriens require only the change of temperature, depending on the type of
promoters.
Some are leaky promoters; thus if the proteins are toxic , cell may die.
b) Coding sequence of the heterologous gene:
Sometimes similar amino acids can interchange, like leucine interchanges with
isoleucine. This does not change the configuration of the native protein but
increase the level of expression.
Expression is often improved by making changes to the nucleotide sequences of the
coding region that dont change the amino acid sequence of the expressed product.
Improvement of expression level been reported by changing G and C residues in
the first few codons to A and T. As GC seems to have more chance of developing
secondary structure so their replacement allows more expression as chances of
forming secondary structure is translation initiation region decreased. In case of
some amino acids several different codons are used; in that case we can use A=T
rich codon instead of GC rich one.
Plasmid that over expressed tRNA molecules that recognized rare codons in the
heterlogous gene have also been reported. One can be introduced in to the E. coli
strain being used for expression as an alternative to changing rare codons in
regular codon sequence.
c) Use of protease deficient host strains:
The uses of host strains ofE.coli carrying mutations which eliminate the production
of cellular proteases can sometimes enhance product accumulation by reducing
degradation of the protein product.
Improving the solubility of the protein
8/8/2019 Protein Sources Final
9/34
The most significant obstacles to the uses ofE.coli are protein insolubility under
conditions of high level expression. To increase solubility following techniques are
proposed:
a) Secretion of the heterologous protein
b) Growth temperature
c) Reduction of rate of protein synthesis
d) Co-expression of chaperones and enzymes influencing folding of the
heterologous protein in vivo
e) In vitro refolding of the heterologous protein
a) Secretion of the heterologous protein:
The periplasmic space comprises ~ 10-40% of the total cell volume under normal
growth conditions and contains ~ 4% of total proteins (100pts). An E.coli secretion
signals sequence attached with heterologous protein direct it into the periplasm.
The signal sequence (18-25 amino acids) is removed during secretion and refolding
of the secretory protein into native conformation occurred resulting in accumulation
of soluble protein in periplasm. So no misfolding occurs, therefore no inclusion
bodies.
In some cases, protein may be secreted in the extracellular media. It could be
spontaneous or as a result of genetic or physiological manipulation which increase
the permeability of the outer membrane. Release of periplasmic proteins in
extracellular space confers further advantages in purification processing.
Incases of secretory and no secretory proteins:
Such secretion can be achieved by using the host own signal sequence or signal
sequence of other E. coli strain or from eukaryotic cells.
The efficiency of signal sequence removal is also influenced by the amino acid
sequence in heterologus protein, especially first few amino acids following the
cleavage site. The protein secretory is native state show better expression after
fusion of signal sequence than that of the native non secretory one.
Disadvantages:
8/8/2019 Protein Sources Final
10/34
Full mechanisms not understood.
Not always effective.
b) Growth temperature:
The improvement of the solubility of proteins expressed in the cytoplasm isachieved by reducing the growth temperature of the culture (to 30 or lower) during
incubation.
Thus, induction by temperature. Optimizing of solubility in the majer concern than
the level if expression. Using weak promoters.
c) Reduction of rate of protein synthesis:
Increased protein synthesis sometimes result in insolubility. Thus protein
production can be reduced by
i) Use of weaker promoter ( e.g. 05mM ITPG )
ii) Providing partial incubation condition ( not switch on the full-blown ; nave
induction is suppressed by the inducer)
iii) Less miss-folding and aggregation
These lead to accumulation of larger amounts of soluble proteins.
c) Co-expression of chaperones and enzymes influencing folding of
the heterologous protein in vivo:
Post translational folding of proteins, assembly into oligomers and transport to the
periplasm are facilitated bye molecular chaperones. Co expression of proteins with
E coli chaperones Gro-Es-Gro-El or DnaJ or DnaK or with Eukaryotic proteins
disulfide isomers, has sometimes proven useful. They are not enzymes, they
recognized the polypeptide released from ribosome and inhibit improper
association of protein and mis-folding.
Molecular chaperones:
Post translational folding of proteins, assembly into oligomers and transport to the
periplasm are facilitated bye molecular chaperones.
8/8/2019 Protein Sources Final
11/34
Molecular chaperons are large group of unrelated protein families to stabilize
unfolded proteins or unfold them for translocation across the membrane or for
degradation and/or to assist in their correct folding or assembly.
they are proteins but not enzymes,
ability to recognize enzymes, partially filded proteins,
not related to protein nature or characteristics
misfolded proteins , unfold, stabilize, unfolded and transported to the
desired location.
Properties of molecular chaperones
1. Molecular chaperones interact with unfolded or partially folded.
2. They stabilize non-native conformation and facilitate the correct folding of
protein subunits.
3. Do not interact with non-native protein nor do they form part of final folded
structure.
4. They are mostly non-specific; interact with a wide variety of polypeptide
chain.
5. Some are specific and restricted to special target.
6. They often couple with ATP-binding and carry out hydrolysis of folded
proteins.
7. They are essential for viability, there is often expression incereased by
cellular structures.
In vitro refolding of the heterologous protein:
Proteins that are made in insoluble form in inclusion bodies can often be solubilized
and refolded. It is not native or completely unfolded protein rather partially folded
intermediate. This inclusion body can be easily separated by centrifugation to
soluble proteins and other cellular components they are less susceptible to
degradation. The major disadvantage is that the conditions for refolding into fully
active form may be difficult to find.
During centrifugation at 500-1000 g inclusion bodies precipitated before cell debris
so easily separated. Solubilization is usually accomplished in two ways:
8/8/2019 Protein Sources Final
12/34
1. With denaturants such as urea or guanidine hydrochloride. Removal
of high molar concentration of urea (6M) used as denaturant by
dialysis or dilution allow to refold
2. By using reducing agents that break disulfide bond.
There are some factors that may be varied to improve the yield of active proteins:
1. Protein concentration ( conc , IB formation )
2. purity
3. pH
4. ionic strength of the buffer
5. the disulfide oxidizing condition which is adjusted by adding
cysteine, arginine, glutathionine or dithiotheitol)
The advantages of expression or heterologous proteins as fusion proteins
or with protein tag:
Many vectors are available which allow expression of heterologous proteins which
are fused at their N or C terminal partners are often termed as protein-tag. For
example, Histidine (His) tag is a fusion protein. Such fusion partners offer several
potential advantages:
A. Improved expression: Fusion of the N terminals of a heterologous
protein to the C-terminus of a highly expressed fusion partner often allow
high level of expression of the fusion protein.
B. Improved solubility: Fusion of N terminus of heterologous protein to the C-
terminus of a soluble fusion partner often improves solubility of a protein.
C. Improved detection: Fusion of a protein at either terminus to a short
peptide or a poly peptide which is recognized by an antibody or binding
protein allows western blot analysis of a protein during expression and
purification.
D. Improved purification: It is a widely used phenomenon. Simple
purification schemes have been described for proteins fused at either end to
tags which bind affinity resins. Available tags includes His6 (six tandem
hisitidine residues); which bind to Ni-NTA (Nitrilo-triacetate chelated with Ni2+
ions), GST (Glutathione-S-transferase, which bind to glutathione-sepharose).
These tags bind to their specific resins and separated easily. There is no
effect of tags on protein and excised easily.
8/8/2019 Protein Sources Final
13/34
Popular yeast hosts utilized in the production of heterologous proteins of industrial
interest include:
1. Saccharomyces cerevisiae
2. Schizosaccharomyces pombe
3. Hansenula polymorpha
4. Kluyveromyces lactis
5. Pichia pastoris
6. Yarrowia lipolytica
7. Candida utilis
Table: 2.6 ( page -66)
Attractive features of yeasts as host for heterologous protein expression:
1. Non pathogenic
2. Rapidly dividing
3. Most yeasts are GRAS listed
4. Easy to grow in laboratory or fermenter
5. Less expertise required
6. Molecular biology/genetic make up well known
7. Eukaryotic cell system so presence of post translational modification is
possible
8. Can be used in many biotechnological processes
Advantages and disadvantages of heterologous protein production in
yeast:
Advantages:
1. Most yeast are GRAS listed
2. Proven history of use in many biotechnological process
3. Fermentation technology is well established
8/8/2019 Protein Sources Final
14/34
4. Ability to carry out post translational modifications in recombinant protein
Disadvantages:
1. Recombinant proteins usually expressed at very low levels, typically
representing only 5% of total cellular protein
2. Retention of many heterologous protein in the periplasmic space
3. Adverse public perception of products manufactured via recombinant
technology
4. Some post-translational modifications differ significantly from those achieved
by animal cells.
Primary and secondary objectives of expression of a heterologous gene in
yeast:
There are two primary objectives:
1. To achieve as high levels of expression of the recombinant protein as possible
2. To ensure that it is authentic in terms of both its primary amino acids
sequences and post-translational modification.
Secondary objectives include:
1. Genetic stability of the expression system
2. Cost effectiveness in terms of media and inducers
General consideration during application of yeast as a suitable expression
system:
1. Approximately 5% genes in S. cerevisiae genome have single intron and S.
cerevesiae is unable to remove that intron from the primary transcript of
heterologous gene. Therefore, it is imperative that a cDNA copy of the
heterologous coding sequence is used as starting point for any expression.
2. If the target protein requires post-translational modifications like disulfide
bond formation, glycosylation, then the protein need to be targeted to the
secretory pathway. Many yeast species, particularly S. cerevisiae have a very
8/8/2019 Protein Sources Final
15/34
low secretory capacity. Thus, the chances of obtaining a high yielding
secretion system are limited, but it is not impossible.
3. The target heterologous protein may be toxic to the yeast cell, even through
the encode protein may not have any associated toxicity in its normal cellular
environment. To solve such problem, it is essential to use an expressionsystem which can be tightly regulated. Such tightly regulated system stops
leaky expression. Such problems arise usually with membrane protein or
membrane associated proteins and they cause inhibition of growth, resulting
in change in biomass.
4. There is no guarantee that there will be a successful outcome to a yeast
expression project. Such failure may occur in spite of optimizing all the
necessary and obvious parameters. Sometimes a low level of expression may
be observed. The reason behind this is unknown. Yeasts are not only
example of unpredictable pool. So a parallel expression system using other
host strains like E. coli is used in simultaneously for the successful expression
of the heterologous protein.
Heterologous protein production in Fungi
Attractive features of fungi as a host for heterologous protein production:
Filamentous fungi represent attractive hosts for heterologous protein production for
a number of reasons:
1. They are enzymatically capable of carrying out post-translational
modification.
2. Many are GRAS-listed
3. They have been extensively employed on an industrial scale for many
decades in the production of a variety of enzymes as well as other primaryand secondary metabolites (e.g., vitamins, organics acids, antibiotics, etc.).
8/8/2019 Protein Sources Final
16/34
4. They are capable of synthesizing and secreting large quantities of certain
proteins into extracellular medium. It is a marked contrast to E. coli or
species ofSaccharamyces..
5. Extracellular production of heterologous proteins is desirable as it simplifies
subsequent product purification.
6. Expression level is very high. Some industrial strains ofAspergillus niger
produce even 20 gram/liter levels of protein (glucoamylase).
7. Large scale fermentation systems been developed and optimized over a long
time, due to their industrial significance.
The major limitation for fungal system in production of heterologous protein is due
to the codon usage. Specific codons for amino acids are used differentially in one
species compared to the species from which the gene was obtained.
Examples of some proteins of industrial significance expressed in
recombinant fungal systems:
Protein Organism
Human interferon Aspergillus niger; A. nidulans
Bovine chymosin A. niger; A. nidulans
Aspertic proteinase (from
Rhizomucor michei)
A. oryzae
Triglyceride lipase A. oryzae
Lactoferrin A. niger; A. oryzae
Plant as a source of industrially important protein
Plants are traditionally used as a source of different biologically active molecules.
Narcotics such as opium are the best known example of such products. Crude
opium consists of dried milky exudates obtained from unripe capsules of certain
species of plants. The most important medical constituents of opium are different
alkaloids, among which morphine is the renounced one. Morphine is extracted and
purified from crude opium preparations, generally by ion exchange
h t h
8/8/2019 Protein Sources Final
17/34
Limitations of higher plants as producers of proteins:
For a number of reasons higher plants are not regarded as good procedures of
commercially important proteins:
1. Plant growth is seasonal in nature; hence a constant production and supply of
product is not possible.
2. Many industrially important proteins synthesized in plants are also found in
other biological sources. In most cases, the alternative source becomes the
active source of choice for both technical and economic reasons.
3. Higher plants tend to accumulate waste substances in structures called vacuoles.
Upon cell disruption these wastes, which include a number of precipitating and
denaturing agents, are released, which may irreversibly inactive many plantproteins.
Some plant proteins and their functions:
A number of industrially important proteins are obtained from plants; two such
proteins include
Monellin and Thaumatin:
These are recognized as the sweetest-known naturally occurring substances.
They are non nutritive sweeteners. Do not promote tooth decay.
Function: Used as sweetening against in food industry and can be safely used as
food ingredients for diabetic patients.
-amylases
Produced by many higher plants, mostly obtained from barley.
Function: These enzymes play an important role in starch-processing industry.
Papain:
Also known as vegetable pepsin. It is the best-known plant-derived protein
produced on industrial scale.
Source: It is collected from the latex of the green fruit and leaves of Carica
papaya.
8/8/2019 Protein Sources Final
18/34
Properties: It is a cysteine protease. Active site contains an essential cysteine
residue which must remain in reduced state to maintain its proteolytic activity. The
purified enzyme exhibits broad proteolytic activity. It consists of a signal
polypeptide chain containing 212 amino acids, with a molecular mass of 23 kDa.
The term papain is applied not only to the purified enzyme but also to the crude
dried latex.
Mechanism of activity: It is used industrially as a meat tenderizing agent.
Proteolytic activity is directed against the collagen fiber, the major structural
protein in animals. Collagen is present in connective tissue and blood vessels
which renders meat though.
Optimum temperature is relatively high (65oC) and remain active up to 90oC. Due
to thermostability, it maintains its proteolytic activity during initial stages of
cooking.
Application: Papain has several industrially important applications, such as
Meat tenderizing
Bating of animal skin
Clarification of beverages
Digestive aid
Debriding agent (cleaning of
wounds)
Before slaughter to relax cattle
collagens.
Ficin:
Another commercially available
protease obtained naturally from plant
sources. It is extracted from the latex
Properties:
1. It is a cysteine protease,
2. got higher proteolytic activity
than papain and has similar
industrial applications.
3. Molecular mass of pure ficin is
~25 kDa.
4. Most large-scale industrial
applications of papain and ficindo not require highly purified
enzyme preparations.
5. Plant enzymes, in particular
those destined for application in
the food processing industry,
must be obtained only from non-
toxic, edible plant species.
8/8/2019 Protein Sources Final
19/34
Production of heterologous
proteins in plants
A number of different heterologous
proteins and peptides are now
produced in a variety of plants.
Genetic manipulation of plant systems
may be undertaken for a number of
reasons.
Introduction of foreign genes or cDNAs
may be performed in order to confer a
novel function or ability on the
manipulated species. Novel DNA
sequences can be introduced and
maintained in plant cells by several
means:
1. Use ofAgrobacterium as carrier
2. Direct injection of DNA into
certain plant cells.
Using such techniques plants can be
engineered to produce insecticides,
which when expressed, may play a
protective role. Their target is often
growth regulatory genes. Sometimes
antibody produced in transgenic plant
called plant body.
Table: - Some Recombinant
proteins of industrial or medical
interest and their plant sources:
Protein Original Expressio
source n system
-amylase Bacillus
licheniformi
s
Tobacco
Chymosin Calf TobaccoErythropoiet
in
Human Tobacco
Glucoamyla
se
Aspergillus
niger
Potato
Growth
hormone
Trout Toba
Interferon- Human Tobacco
Lysozyme Chicken Tobacco
Phytase Aspergillus
niger
Tobacco
Serum
albumin
human Potato
Xylanase Clostridiumthermocell
um
Tobacco
Development of transgenic plant
to carry out heterologous gene
expression:
A transgenic plant is usually
developed using the Ti plasmid of
Agrobacterium tumefaciens. Ti
plasmid has the ability to infect
plant cell and incorporate gene in
the plant chromosomal DNA.
The T-DNA segment of the Ti
plasmid is capable of transferring
8/8/2019 Protein Sources Final
20/34
DNA or gene of heterologous
origin. T-DNA region is bordered
by 25 nucleotides pair imperfect
repeats, one of which must be
present in cis for T-DNA excision
and transfer. The foreign gene
must be inserted between these
two border sequences.
One of the ways of producing
transgenic plant is binary vector
system which is based on the
observation that the T-DNA doesnot need to be physically attached
to the rest of the Ti plasmid. A
two plasmid system, with the T-
DNA on a relatively small molecule,
and the rest of the plasmid in
normal form, is just as effective as
transforming plant cells. The T-
DNA plasmid is small enough to
have unique restriction site and to
be manipulated to insert gene of
target protei
n using standard techniques.
Fig: - The binary vector strategy. Plasmids A and B complement each other
when present together in the same A. tumifaciens cell.(Left figure) The
cointegration strategy. (Right figure)
Advantages and disadvantages of recombinant protein production in
transgenic plants
Advantages:
1 Economically attractive production cost
8/8/2019 Protein Sources Final
21/34
2. Ease of scale up
3. Availability of established practices/equipment for plant harvesting/storage.
4. Elimination of downstream processing requirements if the plant material
containing the recombinant protein can be used directly as the protein
source.
5. Ability to produce target protein in specific plant tissue.
6. New function of protein may evolved
7. Previous functions may enriched
8. Ability to carry out post-translational modification.
Disadvantages:
1. Low expression level ( max 4% xylan by plant of total soluble proteins,
sometimes less than 1%).
2. Glycosylation pattern is usually different from that observed on animal
glycoprotein.
3. Lack of industrial experience or data on large-scale downstream processing ofplant tissue.
4. Seasonal or geographical nature of plant growth
5. Presence of toxic substances is plant cell vacuoles
6. Availability of established, alternative production systems.
Heterologous peptide production in plant cell:
It is possible to produce a range of commercially important peptides in plant
systems like therapeutic proteins. However, plant-based expression systems
achieve glycosylation patterns that differ (in extent and composition) to those
achieved by animal cells. This point is important if an altered glycosylation pattern
in any way negatively influences the recombinant protein product. This is
especially important in the context of therapeutically important glycoproteins,
where an altered glycosylation pattern could influence product safety and/or
efficacy. Certain oligosaccharide epitopes commonly found on plant glycoproteins
8/8/2019 Protein Sources Final
22/34
are highly immunogenic in mammals. This suggests that some mammalian
glycoproteins intended for therapeutic application, if expressed in plant cells, could
potentially be more immunogenic.
Example of small therapeutic peptides produced in plants:
Thyrotrophin: It is a 3 amino acids long peptide, naturally produced in
hypothalamus of mammals. It stimulates the synthesis and release of hormone
from interior pituitary gland.
Some other peptides are produced in minute amount because of difficulties in
synthesis and purification; currently such peptides are chemically synthesized but
the cost of peptide is very high in market. Cost of chemical synthesis increase with
the length of peptide, e.g., 3 amino acids peptide cost less than 5 amino acids one.
Sometimes chemical modifications of peptides are done after observing the
sequence. Now-a-days, some other peptides are produced biotechnologically using
E. coli and yeast expression system.
Seeds of higher plants for protein accumulation:
The ability to target expression of recombinant proteins to a specific plant tissue
can be advantageous. It could reduce the potential toxicity of the protein (for
the plant) and reduce environmental and regulatory concern.
Targeted accumulation of the protein in plant seed is particularly attractive.
The seeds of higher plant naturally contain high levels of storage protein (~50%
of the seed protein). Seeds can be stored for extended period after harvest,
inexpensively and without causing protein degradation. In contrast, plant green
tissue deteriorates rapidly after harvest and requires immediate protein
extraction after harvest, or storage or harvest under refrigeration or frozen
condition (expensive).
Such seed proteins are utilized to synthesize smaller peptides in higher plant. Leu-
enkephalin is an early example of transgenic peptide production in plant.
The recombination was done by inserting the DNA coding sequence of Leu-
enkephain into the gene coding for a seed storage protein termed 25 albumin. The
family of 2S albumins are among the smallest seed storage proteins known, having
a molecular mass in the order of 12 kDa This famil of proteins is deri ed from a
8/8/2019 Protein Sources Final
23/34
group of structurally related genes - all of which exhibit both conserved and
variable sequences. The strategy employed to produce leu-enkephalin involved the
following steps:
1. Substitution of part of the variable region sequence of 2S albumin with DNA
sequence coding for 5 amino acids neurohormone. This DNA construct isflanked on both sides with codons coding for tryptic cleavage sites.
2. Expression of the altered 2S albumin gene resulted in production of a hybrid
storage protein containing the leu-enkephalin sequence.
3. The enkephalin is subsequently released from the altered protein by tryptic
cleavage and purified by HPLC
4. Due to the incorporation of tryptic cleavage sites, the purified product
contained an extra lysine residue which is subsequently removed by
treatment with carboxypeptidase C. (a proteolytic enzyme used to remove
amino acids residue from C-terminal end)
Though it is not a chemically & technically feasible method, it is economically good,
since a number of larger polypeptide have also been expressed in the seeds of
various plants.
Animal tissue as a protein source
A wide variety of commercially available proteins are obtained from animal
sources, especially numerous therapeutic proteins such as insulin and blood
factors. The existence of slaughterhouse greatly facilitates the collection of
significant quantities of the particular tissue required as protein source.
The best known protein obtained from animal source is insulin. It is a
polypeptide hormone that is produced in the pancreas by the beta cells of the
islets of Langerhans. The hormone is used therapeutically in the treatment of
insulin-dependent diabetes (Type 1 diabetes, diabetes mellitus). Until the early
1980s insulin was obtained exclusively from pancreatic tissue derived from
slaughterhouse cattle and pigs. The amount of insulin obtained from the
pancreatic tissue of three pigs satisfies the requirement of one diabetic patient
for appro imatel 10 da s
8/8/2019 Protein Sources Final
24/34
The increasing worldwide incidence of diabetes raised the demand for insulin
which exceeded supply from slaughter house sources. This is no longer of
concern however as potentially unlimited supplies of insulin can now be
produced by recombinant means.
Table: Some proteins of industrial and medical significance traditionallyobtained from animal sources.
Protein Source Application
InsulinPorcine/bovine
pancreatic tissue
Treatment of type 1
diabetes
GlucagonPorcine/bovine
pancreatic tissue
Reversal of insulin
induced hypoglycaemia
Follicle-stimulatory
hormone (FSH)
Porcine pituitary glands
Induction of
superovulation in
animals
Urine of post-
menopausal women
Treatment of (human)
reproductive
dysfunction
Human chronic
gonadotrophin
Urine of pregnant
women
Treatment of
reproductive
dysfunction
Erythropoietin Urine Treatment of anaemia
Blood factors Human plasmaTreatment of
haemophilia
Polyclonal antibodies Human or animal blood
Various diagnostic and
therapeutic applications
Chymosin (rennin) Stomach of calves Cheese manufacture
Significant drawbacks of using proteins from animal sources
therapeutically and its remedy:
Most industrially significant proteins obtained from human and other animalsources are destined for therapeutic use. One most significant disadvantage
8/8/2019 Protein Sources Final
25/34
(especially from human) relates to the potential presence of pathogens in the
raw material.
The large numbers of haemophiliacs who contracted acquired immune
deficiency syndrome (AIDS) from HIV-infected blood transfusion stands as
testament to this fact. Outbreaks of bovine spongiform encephalitis (BSE/Madcow diseases) in cattle herds from various countries serve as another example.
A number of precautions should be taken when animal tissue is used as a protein
source. These include:
1. The use of tissue obtained from disease-free animal only
2. Downstream processing procedure of protein purification must be validated,
thereby must eliminate pathogens which may be present in starting material.
Many pathogens, in particular viruses are markedly species specific. Thus,
therapeutically used proteins obtained from a particular animal species are
better not to administer to other animals of that same species.
Heterologous protein production in transgenic animals- Objectives and
limitations:
Over the past number of years great advances have been recorded in the field
of transgenic animals. The preliminary objective was to improve various animal
characteristics, such as improving the animal growth rate dramatically by
genomic integration of extra copies of growth hormone gene. It is done by
direct microinjection of DNA into ova, although success rate is low.
Molecular farming: All these production of transgenic animal, called molecular
farming. Done by two-
desirable characteristics: One goal of such method is the introduction of specific
functional genes into animals, thereby conferring on them desirable characteristics
such as more efficient feed utilization, improved growth characteristics or
generation of leaner meat.
Increase the target gene product: Another goal of such transgenic technology
is to confer on the transgenic animal the ability to produce large quantities of
industrially important proteins like therapeutic proteins.
8/8/2019 Protein Sources Final
26/34
The production of industrially important proteins has been achieved with
varying degrees of success in mice, goats, sheep and cattle. Initial successes in
expressing high levels of growth hormone in transgenic animals highlighted
some problems associated with the technique:
1. Chronically high circulatory levels of growth hormone (significantly beyondnormal level) resulted in many adverse physiological effects.
2. Elevated circulatory levels of many proteins of potential therapeutic value
would also almost certainly promote similar adverse effects on normal
transgenic animal metabolism.
Specific animal tissues were also targeted as heterologous protein expression
system; examples include:
Mammary gland was the first choice of tissue targeted as heterologous protein
expression site. By targeting expression of the foreign gene into the mammary
gland, the heterologous protein may be secreted directly into the milk.
In mid 1980s, a therapeutic protein, human tissue plasminogen activator (t-PA)
was expressed in mammary gland of transgenic animal (mice) This was
Signal sequence promoter of a milk protein +
Gene encoding the heterologous proteinForeign gene construction
Micro injection into an egg
of target animalEgg fertilization
Implementation of fertilized
egg into a surrogate mother
Embryo is then brought to
term
That transgenic animal is now capable of
secreting the desired protein selectively in its
milk.
Foreign DNA has been
successively incorporated in to
the newborns chromosomal
DNA and expressed.
8/8/2019 Protein Sources Final
27/34
achieved by injecting a DNA construct consisting of promoter and upstream
regulatory sequence from the mouse whey acidic protein gene to the gene
coding for human t-PA into mice embryo. Whey acidic protein is the most
abundant whey protein found in mice milk. Biologically active t-PA was
recovered from the milk of the resultant transgenic mice. t-PA is a serine
protease that converts plasminogen to plasmin. It dissolves fibrin clots and is
used therapeutically in thrombosis (heart vein block). It is also produced in
mammalian cell line.
Desirable features of mammary gland as heterologous expression system:
( over cell culture0
Mammary glands have a number of potential and desirable properties as
heterologous protein expression system than other alternative production methods.
As such-
1. High production capacities: During a typical 5-month period, one sheep
can produce 2-3 litters of milk per day. If the recombinant protein is
expressed at a level of 1g/l, a single sheep could produce in excess of 20g
product/week.
2. Ease of collection of source material: This only requires the animal to
be milked. Commercial automated milking systems are already available;
such systems require only moderate design alteration as they are already
designed to maximize hygienic standards during the milking process.
3. Low capital investment requirements and low operational costs:
Traditional production methods yielding recombinant proteins require
considerable expenditure on fermentation equipment. Using this technology,
such costs are reduced to raising and maintaining the transgenic herbs.
4. Ease of production scale up: Producer animal numbers can be
expanded by breeding programmes.
Draw backs of mammary glands:
1. A number of technical details are yet to be optimized.
2. Yield of heterologous proteins are extremely variable. In some cases, less
than 1mg/l has been found
8/8/2019 Protein Sources Final
28/34
3. Mammary gland tissue is capable of carrying out a broad range of post-
translational modifications of the protein synthesized. Detailed
characterization of the nature of such modifications, particularly in relation to
glycosylation patterns remain to be carried out.
Heterologous protein production using animal cell culture
Animal cell culture also represents an important source of several medically
important proteins, virtually all of which are destined for therapeutic or diagnostic
application; monoclonal antibodies, various vaccines, interferons, factor VIII, t-PA
etc are some of the best known example:
Table :- Some recombinant pharmaceutical proteins approved for general
medical use that are produced commercially via animal cell culture:
Protein Produced in Medical application
Factor VIII CHO cells; BHK Cells Hemophilia A
Factor IX CHO cells Hemophilia B
t-PA CHO cells Heart attacks
FSH CHO cells Infertility
Erythropoietin CHO cells Anemia
Interferon- CHO cells Multiple sclerosis
Several monoclonal
antibodiesHybridoma cells
Various, including
prevention of kidney
transplant rejection and
localization of tumors in
vivo
Difference between animal and microbial cell that influence animal cell
culture and fermentations design:
Animal and microbial cells exhibit many basic differences in their cellular
physiology and structure. Some basic differences that influence animal cell culture
and fermentation design are mentioned below:
1. Animal cells do not possess a cell wall, and thus are more susceptible to
8/8/2019 Protein Sources Final
29/34
2. The nutritional requirements of animal cells are more complex then those of
microbial cells
3. Animal cells tend to have lower oxygen requirements, so used CO2 incubator.
4. The animal cells grow more slowly in artificial media then their microbial
counterpart.
5. Far greater numbers of animal cells are required to seed the fermentation
tank effectively.
Fermentation tanks in which animal cells are cultured usually contain agitation
blades of modified design in order to reduce the potential physical damage caused
by shear forces generated by such rotating blades. Moreover, fermentations are
usually conducted in air-lift reactors, in which liquid culture motion is promoted
within the vessel by sparging an air-CO2 mixture into the reactor in order to further
reduce shear force.
Fig: - Design of a generalized microbial cell fermentation vessel (a), andan animal cell bioreactor (b). Animal cell bioreactors display several structuraldifferences as compared to microbial fermentation vessels, in particular, (i) the useof a marine type impeller (some animal cell bioreactors-air-lift fermenters aredevoid of impellers, and use sparging of air-gas as the only means of mediaagitation); (ii) the absence of baffles and; (iii) curved internal surfaces at thebioreactor base. These modifications aim to minimize damage to the fragileanimal cells during culture.
8/8/2019 Protein Sources Final
30/34
Serum replacements are mixture of nutrient supplemented with variety of
purified proteins like insulin, epidermal growth factor, transferrin, prolactin,
prostaglandin E1, ethanol amine, phosphoethanol amine Hydrocortisone etc.
Bacterial and fungal contamination is one of the fundamental problems of
animal cell culture. To overcome this problem high concentration of antibioticslike penicillin, streptomycin, gentamycin etc. are used to avoid microbial
contamination.
Prerequisite:
Sterile tissue culture flask
Pipettes (sterile 1 ml, 5 ml, 10 ml)
Sterile Pasteur pipette
Sterile plastic conical tubes
Sterile cryo-tubes
Hemocytometer
Laminar flow
CO2 incubator
Liquid N2 freezer
Inverted microscope
Vacuum line
Double distill H2O used in
sterilization
Sterile hood
Maintain personal hygiene
Media compositions and other prerequisites for animal cell culture:
Animal cells are more complex compared with microbial cells and their cultures are
more fragile compared with bacterial, fungal and yeast cultures due to their
requirement of complex media and their nutritional requirements which are more
expensive than microbial culture media. Previously several living system fluids likeserum, lymph, embryo, homogenate etc are used as major source of nutrients. But
their exact composition was unknown.
Currently two different types of growth media for animal cell culture are available.
Those are
a) Typical serum containing growth medium - that contains:
Serum (5-20%) Nitrogen sources
8/8/2019 Protein Sources Final
31/34
Vitamins
Trace elements
Trace elements
Growth factors
Buffers in water
b) Serum free growth medium - that contains:
1. Amino acids 2. Serum replacements
3.Vitamins
4.Major inorganic salts
5.Other organics
6.Trace elements
7.Buffers and indicators
8/8/2019 Protein Sources Final
32/34
Generation of primary cell line:
Most of the primary cell line taken from embryo of different animals as they
dissociate easily and have a longer life time. Adult cells may not dissociate easily
and have limited/shorter life span.
1. Tissues excised from specific
organs of animals or embryo of
animals.
2. Mechanical/biochemical
treatments to dissociate them
3. Frozen in liquid N2 freezer.
4. Specific amounts of cells taken
out.
5. Primary cell line
6. Subculture on medium, maintain
time interval
7. Repeating subculture
8. Maintain cell line
9. Transferring old media (sub-
culturing)
10.Secondary cell line
Trypsin is usually used to treat cell culture to dissolve extracellular attachment and
to get single cells in floating conditions. Cells are washed with PBS with no calcium
(Ca2+) because Ca2+ play role in cell attachments.
Maintenance of cell culture:
A number of defined media have been developed to grow and maintain cell line.
Among them
1. Eagles modified Eagles medium (MEM)
2. Dulbeccos modified Eagles medium (DMEM) are most popular
Madam used DMEM media-composition given below:
1. 10 ml glutamine (2%)
2. 5 ml penicillin + streptomycin
(1%)
3. 50 ml serum (10%)
4. 450 ml media
5. Total 500 ml (some media lost
during sterilization)
Tissue culture flask containing exponentially growing cell line:
8/8/2019 Protein Sources Final
33/34
1. Observe the presence of cell line
under an inverted microscope.
2. Aspirate the old media with the
aid of a Pasteur pipette.
3. Add 3-5 ml PBS slowly
4. Aspirate PBS
5. Add 3-5 trypsin (30 sec room
temperature)
6. Aspirate trypsin
7. Everything must be pre-warmed
(37oC) before use
8/8/2019 Protein Sources Final
34/34